Promotional Information

Cutting-edge review concerning the molecular and cellular biology of vitamins and hormones

Table of Contents

Novel Neuropeptides in the Control of Food Intake: Neuronostatin and Nesfatin-1Gina L.C. Yosten
Anorexia and Hypothalamic DegenerationIda A.K. Nilsson, Charlotte Lindfors, Martin Schalling, Tomas Hökfelt, and Jeanette E. Johansen
The Role of Ghrelin in Anorexia-Cachexia Syndromes Bobby Guillory, Andres Splenser, and Jose Garcia
Ghrelin Gene Variants and Eating DisordersTetsuya Ando
Steroid Metabolism and Excretion in Anorexia NervosaWassif Samuel Wassif and Andrew Rashad Ross
Anorexia Nervosa and Estrogen ReceptorsNicolas Ramoz, Audrey Versini, and Philip Gorwood
Cannabinoid Receptors and Cholecystokinin in Feeding InhibitionFrancisco Alén Fariñas, M. Teresa Ramírez-López, Raquel Gómez de Heras, Fernando Rodríguez de Fonseca, and Laura Orio
Treatment of Cachexia: Melanocortin and Ghrelin InterventionsJeremy Steinman and Mark Daniel DeBoer
The Influence of Estrogen Therapies on Bone Mineral Density in Premenopausal Women with Anorexia Nervosa and AmenorrheaJocelyn Lebow and Leslie Sim
Clinical and Hormonal Variables Related to Bone Mass Loss in Anorexia Nervosa PatientsMaria Luisa Fernandez-Soto, Amalia Gonzalez-Jimenez, Marta Chamorro- Fernandez, and Socorro Leyva-Martinez
Mechanism-Based Therapeutic Approaches to CachexiaFabio Penna, Gabriella Bonelli, Francesco M. Baccino, and Paola Costelli
Cisplatin-Induced Anorexia and GhrelinTomohisa Hattori, Koji Yakabi, and Hiroshi Takeda
Anorexia of Aging Zbigniew Kmiec, Erika Petervari, Marta Balasko, and Miklos Szekely

About the Author

Trained in biochemistry at the University of Wisconsin, Madison, Dr. Litwack worked on enzymology and the effects of hormones on enzyme systems. Then he was a Postdoctoral Fellow of the National Foundation for Infantile Paralysis at the Biochemical Institute of the Sorbonne in Paris. Dr. Litwack's first position was as Assistant Professor of Biochemistry at Rutgers University in 1954. Six years later, he joined the University of Pennsylvania as associate professor and four years later went to the Fels Institute for Cancer Research and Molecular Biology, as full professor, eventually becoming Deputy Director of the Institute. In 1991, he accepted the Chair of Pharmacology at Thomas Jefferson University where he is also Deputy Director of the Jefferson Cancer Institute and Associate Director for Basic Science in the Jefferson Cancer Center. Dr. Litwack's work has been in the area of mechanisms of steroid receptor action involving especially the glucocorticoid and mineralocorticoid receptors, immunophi.